Vitamin E δ-Tocotrienol Administered to Subjects With Resectable Pancreatic Exocrine Neoplasia

NCT00985777 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

26

Enrollment

OTHER

Sponsor class

Conditions

Pancreatic Neoplasms

Interventions

DRUG: Vitamin E δ-Tocotrienol

Sponsor

H. Lee Moffitt Cancer Center and Research Institute

Collaborators

[object Object]